Are beta2-adrenoceptor polymorphisms important in asthma--an unravelling story (Q45121018)

9 December 2017

Are beta2-adrenoceptor polymorphisms important in asthma--an unravelling story (English)

1 reference

9 December 2017

1 reference

2

1 reference

9 December 2017

A E Tattersfield

1

1 reference

PubMed ID

15500871

9 December 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

9 December 2017

1 reference

9 December 2017

364

1 reference

9 December 2017

9444

1 reference

9 December 2017

1464-1466

1 reference

Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network

9 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917286-3

7 January 2021

Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917286-3

7 January 2021

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917286-3

7 January 2021

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917286-3

7 January 2021

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917286-3

7 January 2021

Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917286-3

7 January 2021

Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917286-3

7 January 2021

Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917286-3

7 January 2021

Association of Glu 27 beta 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917286-3

7 January 2021

Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917286-3

7 January 2021

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917286-3

7 January 2021

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917286-3

7 January 2021

Beta2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917286-3

7 January 2021

The beta-agonist controversy revisited.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2917286-3

7 January 2021

10.1016/S0140-6736(04)17286-3

Identifiers

DOI

1 reference

9 December 2017

1 reference

PubMed ID

15500871